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Abstract
Objective: Increased risk for atherosclerosis is associated with infectious diseases including periodontitis. Natural IgM
antibodies recognize pathogen-associated molecular patterns on bacteria, and oxidized lipid and protein epitopes on low-
density lipoprotein (LDL) and apoptotic cells. We aimed to identify epitopes on periodontal pathogen Porphyromonas
gingivalis recognized by natural IgM binding to malondialdehyde (MDA) modified LDL.
Methods and Results: Mouse monoclonal IgM (MDmAb) specific for MDA-LDL recognized epitopes on P. gingivalis on flow
cytometry and chemiluminescence immunoassays. Immunization of C57BL/6 mice with P. gingivalis induced IgM, but not
IgG, immune response to MDA-LDL and apoptotic cells. Immunization of LDLR2/2 mice with P. gingivalis induced IgM, but
not IgG, immune response to MDA-LDL and diminished aortic lipid deposition. On Western blot MDmAb bound to P.
gingivalis fragments identified as arginine-specific gingipain (Rgp) by mass spectrometry. Recombinant domains of Rgp
produced in E. coli were devoid of phosphocholine epitopes but contained epitopes recognized by MDmAb and human
serum IgM. Serum IgM levels to P. gingivalis were associated with anti-MDA-LDL levels in humans.
Conclusion: Gingipain of P. gingivalis is recognized by natural IgM and shares molecular identity with epitopes on MDA-LDL.
These findings suggest a role for natural antibodies in the pathogenesis of two related inflammatory diseases,
atherosclerosis and periodontitis.
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Introduction
Atherosclerosis is a chronic inflammatory disease [1] and
infections potentially contribute to atherogenesis with local
inflammatory changes on the vascular wall [2]. Conventional risk
factors of cardiovascular disease (CVD) such as hypercholesterol-
emia, hypertension, smoking or diabetes can be attributed to the
majority of CVD incidences but the effects of genetic and
environmental factors are also acknowledged [3]. Viral and
bacterial pathogens are encountered by the immune system, and
many studies report that infectious burden with several pathogens
associates with the progression of atherosclerosis independently of
classic risk factors [4].
Lipoprotein oxidation is essential for initiation and progression
of atherosclerosis. Oxidized lipid epitopes are generated on low-
density lipoprotein (LDL) by lipid peroxidation reactions of
polyunsaturated fatty acids producing reactive aldehydes, such as
malondialdehyde (MDA) and 4-hydroxynonenal, which form
covalent adducts with lysine residues of apolipoprotein B or
amino-containing phospholipids of LDL [5,6]. Additionally,
oxidation of phospholipids exposes the phosphocholine (PC)
moiety, which is found on oxidized LDL (OxLDL) and bacterial
cell wall polysaccharides on for example Streptococcus pneumoniae [7].
Oxidatively modified lipoproteins participate in the inflammatory
processes of atherogenesis and contain highly immunogenic
epitopes that are targeted by the natural antibodies of the innate
immune system [8].
Infectious pathogens and apoptotic cells have also been reported
to contain structural motifs recognized by natural antibodies [9].
Oxidative modifications of lipoproteins generate epitopes that are
a class of pathogen-associated molecular patterns (PAMP) or
danger-associated molecular patterns (DAMP) recognized by
components of innate immune system [10]. Natural IgM
antibodies recognize the molecular mimicry between epitopes of
bacterial PAMPs and OxLDL [9], and autoantibodies to oxidized
lipid and protein epitopes on LDL are present in both humans and
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mice [11–13]. IgM antibodies to OxLDL are reported to be
required for atheroprotection in mice [14] although some
controversial data [15] exists. LDL receptor (LDLR2/2) and
apolipoprotein E –deficient (apoE2/2) mice generate autoanti-
bodies to MDA modified LDL (MDA-LDL) representing epitopes
different from the structure of PC, and immunization of mice with
MDA-LDL has been demonstrated to reduce atheroprogression
[11,16]. MDA and related aldehydes are abundantly generated in
biological lipid peroxidation [17], and already at the time of birth
humans have natural IgM recognizing MDA epitopes [18].
Epidemiological studies in humans suggest that IgM antibodies
to OxLDL are associated with lower incidence of atherosclerosis
[12]. IgG antibodies to OxLDL, on the contrary, have been
reported to associate with an increased risk for atherosclerosis [13].
IgM antibodies to oxidized lipid and protein epitopes are proposed
to reduce foam cell formation by blocking the uptake of OxLDL
by macrophage scavenger receptors [19,20].
Periodontal diseases cause a progressive destruction of the
tooth-supporting tissue and are associated with an increased risk
for CVD in humans [21,22]. Porphyromonas gingivalis is considered
as one of the principal pathogens for chronic adult periodontitis.
In animal models, infection with live P. gingivalis accelerates
atherosclerosis in homo- and heterozygous apoE-deficient mice
[23–27]. Conversely, atheroprogression can be prevented with P.
gingivalis immunization using heat-killed bacteria [25,28]. The
major virulence factors of P. gingivalis include fimbriae, lipopoly-
saccharides and various proteases and hemagglutinins. Proteases
named arg-gingipain (Rgp) and lys-gingipain (Kgp) are important
for the virulence of P. gingivalis as they elicit dysfunction of
inflammatory and immune responses and can degrade various
connective tissue proteins [29]. However, precise molecular
mechanisms of how oral pathogens accelerate atherosclerosis are
still unclear.
The aim of the present study was to characterize new epitope
cross-reactivity, other than the previously described PC, between
oxidized LDL and bacteria. We focused on natural IgM against
MDA epitopes on LDL because MDA is a naturally occurring
aldehyde targeted by antibodies present at birth and IgM
antibodies to MDA-LDL associate with diminished atheropro-
gression. We screened few bacterial species for recognition by anti-
MDA-LDL IgM, and P. gingivalis was assessed in more detail since
some strains of P. gingivalis are previously determined as devoid of
PC [30]. We investigated the effect of P. gingivalis immunization on
the induction of anti-MDA-LDL antibodies and on the progres-
sion of atherosclerosis in mice. Further, we identified proteins of P.
gingivalis recognized by anti-MDA-LDL-IgM with mass spectrom-
etry, and assessed if human sera IgM recognized the P. gingivalis
epitope sharing molecular identity to MDA-LDL.
Methods
Cloning of mouse monoclonal IgM
Splenocytes from a naı¨ve apoE2/2 mouse (C57BL/6 back-
ground B6.129P2-Apoetm1N11, Taconic, Denmark) were fused with
P3663Ag8.653.1 myeloma cells using standard methods. Spleno-
cyte-myeloma hybridoma cells were grown in Dulbecco’s modified
Eagle’s medium (Sigma, St. Louis, MO) supplemented with 20%
fetal bovine serum (HyClone laboratories, South Logan, UT,
USA), 1% non-essential amino acids, 10 mM HEPES, 50 mM b-
mercaptoethanol, 100 U/ml penicillin and 100 mg/ml streptomy-
cin (Sigma, St. Louis, MO, USA). Cells were maintained in a
humidified atmosphere with 5% carbon dioxide at +37uC. For
large scale production of mouse mAbs the hybridomas were
cultured in serum-free HyClone SFM4MAb-Utility medium
(HyClone Laboratories) with antibiotics for 12 days. Hybridoma
cultures were tested for production of IgM to MDA-LDL, and
IgM was purified with Sepharose 6 100/300 GL gel filtration
column (GE Healthcare Bio-Sciences, Piscataway, NJ, USA) and
analyzed for purity on sodiumdodecylsulphate polyacrylamide gel
electrophoresis (SDS-PAGE). Mouse monoclonal IgM, MDmAb
(clone HME-04_7), was selected for this study. According to the
sequence analysis the variable regions of MDmAb’s heavy and
kappa light chain were .90% identical to the corresponding
mouse germ-line gene sequences (data not shown). Isotype control
IgM (clone HMC-06_29) was generated from a naı¨ve C57BL/6
mouse using similar methods. Anti-PC-IgM control antibody
(EO6) [31] was a kind gift from Professor J. Witztum, University of
California, San Diego, USA.
LDL isolation and modifications
Low-density lipoprotein fraction (density 1.019–1.063 g/ml)
was isolated from human plasma by sequential density gradient
centrifugation [32]. Malondialdehyde (MDA) modification to LDL
was prepared as described [33]. In brief, 0.5 M solution of 1,1,3,3
– tetramethoxypropane malonaldehyde-bis(dimethyl acetal) (Sig-
ma Aldrich) in 0.3% hydrochloric acid was incubated at +37uC for
10 minutes. pH was adjusted between 6.0 and 7.0 with sodium
hydroxide and the final volume was adjusted to 4 ml with sterile
water. A total of 900 ml of 0.5 M MDA was added to 6 mg LDL
and the volume was adjusted to 3 ml. The mixture was incubated
at +37uC for three hours and dialysed extensively against
0.27 mM EDTA (ethylenediaminetetraacetic acid) in phosphate
buffered saline (PBS). The percentage of modified lysine residues
was determined with TNBS (2,4,6 – trinitrobenzene sulphonic
acid trihydrate; Fluka Chemika) testing [34]. Malondialdehyde
acetaldehyde (MAA) modification was performed as described
[35,36]. 0.5 M MDA solution was prepared as described and pH
was adjusted to 4.8. A total volume of 310 ml PBS, 140 ml of 20%
acetaldehyde, 5 mg LDL and 300 ml 0.5 M MDA were mixed in
this order. pH was adjusted to 4.8 and the mixture was incubated
at +37uC for two hours. Buffer of MAA-LDL was changed into
0.27 mM EDTA in PBS with Amicon Ultra-4 Ultracel MWCO
10,000 filters (Millipore). Fluorescent MAA-residues were mea-
sured at excitation wavelength of 355 nm and emission wave-
length of 460 nm with Victor2 multilabel reader (Perkin Elmer).
Copper oxidized LDL (CuOx-LDL) was prepared by incubating
LDL with 4 mM CuSO4 for 24 hours at +37uC. Reaction was
stopped by adding EDTA to a final concentration of 200 mM, and
LDL was dialysed [37].
Bacteria
Oral pathogenic bacteria Porphyromonas gingivalis (Pg) strains
representing three serotypes, ATCC 33277, W50 and OMGS 434,
were used in the study and cultured on Brucella agar plates supple-
mented with 5% horse blood, 5 mg/ml hemin and 100 mg/ml
vitamin K1 anaerobically for 5 to 6 days. Purity of the cultures was
checked by colony morphology and Gram-staining. Heat-killed P.
gingivalis was prepared by incubation at 60uC for one hour in PBS,
and used for immunizing C57BL/6 mice. For other assays,
including immunization of LDLR2/2 mice, the bacteria were
fixed overnight in 0.5% formalin in PBS and washed extensively
with PBS. P. gingivalis suspensions were adjusted to an absorbance
of 0.15 at 580 nm for chemiluminescence immunoassays and three
strains were mixed in equal volumes [38]. For flow cytometry
assays P. gingivalis cells were picked from plates and suspended in
PBS. Escherichia coli BL21(DE3) (Invitrogen, Eugene, OR, USA)
cells were washed from culture medium with PBS for flow
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cytometry and treated with 0.5% formalin in PBS overnight for
chemiluminescence immunoassay.
Chemiluminescence immunoassays and Western blotting
MDA-LDL, MAA-LDL, native LDL and PC-conjugated
bovine serum albumin (PC-BSA) (Biosearch Technologies, No-
vato, CA, USA) were used as antigens (5 mg/ml) in chemilumi-
nescence immunoassays [12,33]. P. gingivalis suspensions were
adjusted to an absorbance of 0.15 at 580 nm and three strains
were mixed in equal volumes. Specific binding of MDmAb to
bacteria, modified and native LDL, PC-BSA and recombinant
domains of gingipain (Rgp) was tested with competitive chemilu-
minescence immunoassay. MDA- and MAA-modified, native
LDL and PC-BSA (0–100 mg/ml) and Rgps (0–200 mg/ml) were
incubated with 0.3 mg/ml MDmAb diluted in 0.5% fish gelatin –
0.27 mM EDTA in PBS (FG-buffer) overnight at +4uC and the
samples were centrifuged at 16,0006g at +4uC. 96-well microtiter
plates with 5 mg/ml immobilized antigens were washed with
0.27 mM EDTA in PBS three times between each step of the
immunoassay. FG-buffer was used for blocking the plates before
adding 1.25 mg/ml mouse monoclonal antibodies and diluted
plasma in duplicates or competition samples in triplicates. Alkaline
phosphatase conjugated secondary antibodies (Sigma, St. Louis,
MO, USA) and Lumiphos 530 substrate (Lumigen Inc. Southfield,
MI, USA) were used for chemiluminescence detection. IgM
binding to bacteria and recombinant proteins was analyzed by
SDS-PAGE and Western blotting using anti-mouse-IgM-Alexa
Fluor 680 antibody (Invitrogen) for detection, and the nitrocellu-
lose membranes were imaged with Odyssey infrared scanner (LI-
COR, Lincoln, NE, USA).
Protein identification by mass spectrometry and
proteome data analysis
Excised gel bands matching to MDmAb immunostaining were
washed and dehydrated with acetonitrile (ACN). Proteins were
reduced with 20 mM dithiothreitol and incubated at 56uC for
30 min before alkylation with 55 mM iodoacetamide - 0.1 M
ammonium hydrogen carbonate (NH4HCO3) in the dark at room
temperature for 15 minutes. After washing with 0.1 M NH4HCO3
and dehydration with ACN the gel pieces were rehydrated in 10 to
15 ml sequencing grade modified trypsin (Promega, USA) in 0.1 M
NH4HCO3, to a final concentration of 0.01 mg/ml trypsin and
incubated for digestion overnight at 37uC. Tryptic peptides were
eluted from the gel pieces by incubating successively in 25 mM
NH4HCO3 and then twice in 5% formic acid for 15 minutes at
room temperature each. The resulting tryptic digest peptides were
desalted using Zip Tip mC-18 reverse phase columns (Millipore,
USA) and directly eluted with 50% ACN - 0.1% trifluoroacetic
acid (TFA) onto MALDI target plate. A saturated matrix solution
of a-cyano-4-hydroxy cinnamic acid (CHCA) (Sigma, USA) in
33% ACN - 0.1% TFA was added [39].
MALDI-TOF analyses were carried out with Autoflex III
(Bruker Daltonics, Bremen Germany) equipped with a Smart-
BeamTM laser (355 nm), operated in positive and reflective modes.
Typically, mass spectra were acquired by accumulating spectra of
2000 laser shots and up to 10000 for MS/MS spectra. External
calibration was performed for molecular assignments using a
peptide calibration standard (Bruker Daltonik GmbH, Leipzig,
Germany). Trypsin autolytic peptide masses were used to check or
correct the calibration. These autolytic peptides and with keratin –
derived ones, when present, were removed before search
submission. Protein identifications were performed by combining
the files (PMF and few Lift spectra (MSMS) originating from the
same spot) and searching against SwissProt database. ‘Other
bacteria’ was selected in taxonomy field (over 42100 sequences)
using Matrix Science’s Mascot (Matrix Science Ltd, UK).
FlexAnalysisTM v3.0 and BiotoolsTM v3.1 softwares (Bruker
Daltonics) were used to assign molecular isotopic masses to the
peaks in the MS spectra and as search engine interface between
mass list data transfer and the databases in Mascot server,
respectively. The following parameters were set for the searches:
0.1 Da precursor tolerance and 0.5 or 1 Da MS/MS fragment
tolerance for combined MS and MS/MS searches, fixed and
variable modifications were considered (carbamidomethylated
cysteine and oxidized methionine, respectively), one trypsin missed
cleavage was allowed. Protein identifications were further
evaluated by comparing the calculated and observed molecular
masses, as well as the quality of MS/MS mass spectra and their
amino acid sequence matching to the identified peptides [40].
Production of recombinant gingipain
Purified genomic DNA of P. gingivalis ATCC 33277 was used as
the template for amplifying rgpA. The primers were designed to
amplify sequences coding for the catalytic domain (CAT) (amino
acid residues 225–716) and two sequences at adhesin/hemagglu-
tinin domain, Rgp44 (amino acid residues 717–1135) and Rgp15–
27 (amino acid residues 1136–1703) (modified from Inagaki et al.
2003) [41]. The primer sequences for RgpCAT were forward 59-
GGTATTGAGGGTCGCATGTACACACCGGTAGAGGAAA
AACAAAATGGTC-39, and reverse 59-AGAGGAGAGTTA-
GAGCCTTAGCGAAGAAGTTCGGGGGCATCGCTG-39. For
Rgp44 the forward primer was 59-GGTATTGAGGGTCGCAT-
GAGCGGTCAGGCCGAGATTGTTCTTG-39 and the reverse
59-AGAGGAGAGTTAGAGCCTTAGCGCTTGCCGTTGGC
CTTGATCTC-39. For Rgp15–27 the forward primer was 59-
GGTATTGAGGGTCGCATGGCAGACTTCACGGAAACGT
TCGAGTC-39 and the reverse 59-AGAGGAGAGTTAGAG
CCTTACTTTACAGCGAGTTTCTCTACGTAAG-39. The
polymerase chain reaction amplification was performed using
the following cycles 35 times: denaturation at 98uC for 10 seconds,
annealing and extension at 72uC for 30 seconds. PCR products
were visualized on 1% agarose gel. Ligation of the inserts to the
expression vector was performed by using pET32 Xa LIC vector
kit according to manufacturer’s instructions (Novagen, Madison,
WI, USA). Purification of the histidine-tagged recombinant
proteins followed the protocols of ProBond Purification System
(Invitrogen, Carlsbad, CA, USA) with slight modifications. E. coli
BL21(DE3) were harvested by centrifugation at 3,0006 g for
10 minutes and suspended in native lysis buffer containing 50 mM
Tris – 25 mM sodium chloride – 2.5 mM magnesium chloride –
0.1 mM calcium chloride pH 8.0. Lysozyme was added 1 mg/ml
and incubated at 30uC for 30 minutes. Bacteria were sonicated
7610 seconds and treated with DNase I (Fermentas) 4 U/ml for
15 minutes on ice. Cellular debris was collected by centrifugation
at 3,0006 g for 15 minutes. Soluble Rgp15–27 protein was
purified from the supernatant. Recombinant Rgp44 and RgpCAT
were expressed as inclusion bodies remaining in the cell pellet after
native lysis. Rgp44 and -CAT were purified from E. coli cells by
denaturing lysis with 6 M guanidium hydrochloride for 10 min-
utes. The lysate was homogenized with a needle and a syringe and
sonicated 365 seconds. Viscous cell debris was separated by
ultracentrifugation at 100,0006 g for 30 minutes. Soluble
proteins in the supernatant were bound to nickel chelating slurry
following manufacturer’s protocols. Phosphate buffers without
urea were used in wash and elution steps for all Rgps. Purity of the
histidine-tagged recombinant proteins was analyzed on SDS-
PAGE. Small molecular weight protein contaminants were
removed with Amicon Ultra-4 Ultracel MWCO 30,000 filters
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(Millipore) for immunoassays using Rgps as immobilized anti-
gens. For detailed description of the purification protocol see
Methods S1.
Animals, diets and immunization
Female LDLR2/2 mice (C57BL/6J background B6.129S7-
Ldlrtm1Her) were evenly grouped according to the age and weight
and kept in conventional housing. Primary immunizations without
adjuvant were performed for LDLR2/2 mice (n = 7) by
subcutaneous injections of killed whole bacteria (50 mg protein)
representing the three strains of P. gingivalis mixed in equal
volumes [38]. Control group received sterile PBS (n = 8). Three
boosters (25 mg protein) were given intraperitoneally at two-week
intervals. During the immunization period LDLR2/2 mice were
fed regular chow (4.4% fat and 0.01% cholesterol) followed by
Western type high fat diet (HFD) (22% fat and 0.15% cholesterol
(TD88137 Harlan Teklad, Madison, WI, USA) for 15–18 weeks.
Booster injections were given once a month during HFD.
Female C57BL/6 mice on chow diet (n = 8) were immunized
without adjuvant with one strain of heat-killed P. gingivalis (ATCC
33277, 26108 CFU) in sterile saline injected subcutaneously. We
confirmed that the recognition of epitopes on P. gingivalis by
MDmAb was not dependent on the strain i.e. gingipain was
detected in immunoblots in all three strains similarly. Boosters
(16108 CFU) were injected intraperitoneally three times every two
weeks. Controls received sterile saline (n = 8).
Mouse blood samples before and during the immunizations
were taken from the hind leg vein into Microvette CB 300 lithium-
heparin tubes (Sarstedt, Nu¨mbrecht, Germany) and plasma was
separated at 2,0006 g for 5 minutes. The mice were sacrificed
with carbon dioxide inhalation and blood samples were immedi-
ately collected from the vena cava into syringes primed with
EDTA and plasma was separated.
Analysis of atherosclerosis and plasma lipids in mice
The LDLR2/2 mice were sacrificed by carbon dioxide
inhalation and blood was collected from vena cava. The aorta
was perfused for 10 minutes with PBS containing 1 mg/ml
butylated hydroxytoluene (BHT) via a cannula inserted into the
left ventricule and fixed by perfusion with formalin-sucrose
solution pH 7.4 (10% formalin - 5% sucrose - 3 mM EDTA -
20 mM BHT) for 10 minutes. Dissected aortas were stained with
Sudan IV (Sigma Aldrich, St. Louis, MO, USA). Each aorta was
then longitudinally opened and pinned to obtain a flat preparation
for en face lesion size analysis [42,43]. Aortic plaque areas were
determined with MCID Core 7.0 Image analysis software
(InterFocus Imaging, Cambridge, UK). The extent of atheroscle-
rosis at the aortic origin was determined with the same image
analysis system. Aortic sections were collected throughout the
length of the aortic valve leaflets. Three 5 mm thick sections were
consecutively collected onto an object glass, and every third glass
was stained with hematoxylin-eosin. All stained sections were
analyzed for total plaque area. Lining of the plaque area followed
adventitia-media border and intima-lumen border at the luminal
edge. Cross-sectional area of the aorta was determined following
the adventitia-media border [42,43]. The final value of plaque
area for each mouse was the mean of nine consecutive stained
sections from the thickest region of the plaque. Plasma total
cholesterol, total triglycerides and HDL cholesterol in LDLR2/2
mouse plasma were determined after HFD by enzymatic methods
using commercial kits from Roche Diagnostics, Mannheim,
Germany. LDL cholesterol was estimated using the formula of
Friedewald [44].
Flow cytometry for IgM binding to bacteria and
apoptotic cells
Apoptosis was induced in human Jurkat T cells by UV-
irradiation (51 mJ/cm2) [33,45]. Apoptotic cells were identified
with propidium iodide (PI) staining (1 mg/ml). Binding of C57BL/
6 mouse plasma IgM to apoptotic cells, and mouse monoclonal
IgM binding to bacteria was analyzed with FACSCalibur (BD
Biosciences, San Jose, CA, USA) using anti-mouse-IgM Alexa
Fluor 488 (Invitrogen). Data was analyzed using FCS Express V3
software (De Novo Software, Los Angeles, CA, USA).
Human serum immunoassay
Fasting blood samples were collected from 29 healthy adult
volunteers (5 men and 24 women) and serum was separated.
Serum IgM and IgG binding to P. gingivalis and MDA-LDL was
analyzed by chemiluminescence immunoassays. Competitive
immunoassay was used for determining the specificity of human
serum IgM binding to the recombinant gingipain.
Ethics statement
The animal protocol was approved by the National Animal
Experiment Board, Finland (STH1164A), and the animal studies
were carried out according to the approved guidelines.
Collection of human serum samples was carried out in
accordance with the Declaration of Helsinki and approved by
the Ethical Committee of the Oulu University Hospital, Finland
(21/2006). A written informed consent was obtained from each
participant.
Statistical analysis
Two-tailed Student’s t-test was used for analyzing the
significance of the differences between variables. P-values less
than 0.05 were considered significant. * P,0.05, ** P,0.01; ns,
non-significant. Data are presented as mean 6 SD. Spearman
rank correlation tests were performed to determine the relation-
ship between the variables that had skewed distribution. The box-
and-whisker plots represent quartiles, the median and the mean
(black square). The whiskers denote the 10th and 90th percentiles
and asterisks denote minimum and maximum values.
Results
Cross-reactive epitopes on OxLDL and P. gingivalis
recognized by natural IgM
Mouse monoclonal IgM to MDA-LDL (MDmAb, clone HME-
04_7) was analyzed for binding to bacterial epitopes on P. gingivalis
(Pg). Western blotting was performed to assess binding of MDmAb
to proteins of Pg (Fig. 1A). Four bacterial protein fragments of
approximately 45, 40, 32 and 30 kDa were recognized by
MDmAb. No binding to PC-BSA was observed. Anti-PC-IgM
control antibody (a-PC-mAb) did not bind to Pg in Western blot
(Fig. 1A) validating that the bacterial PC-epitopes were not present
in the ATCC33277 strain. Direct binding immunoassay showed
MDmAb binding to epitopes on MDA- and malondialdehyde
acetaldehyde (MAA) modified LDL, but not to native LDL
(nLDL) or PC-BSA (Fig. 1B). MDmAb bound specifically to
MDA-LDL, MAA-LDL (Fig. 1C) and P. gingivalis (Fig. 1D) but not
to nLDL (Fig. 1C) or E. coli (Fig. 1D) in competitive immunoassays.
Binding of MDmAb to bacteria was further confirmed in native
conditions by flow cytometry. MDmAb bound to P. gingivalis cells
(Fig. 1E), but not to E. coli (Fig. 1F). Thus, recognition of P. gingivalis
by natural IgM was demonstrated to occur through epitopes sharing
molecular mimicry with MDA-LDL.
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Figure 1. Cross-reactive epitopes on MDA-LDL and bacteria. Binding of anti-MDA-LDL-IgM (MDmAb) and anti-PC-IgM control antibody (a-PC-
mAb) to P. gingivalis (Pg) and PC-conjugated bovine serum albumin (PC-BSA) on Western blot (A). Binding of MDmAb to MDA- and MAA-modified
and native LDL (nLDL) and PC-BSA using direct binding (B) and competitive (C) chemiluminescence immunoassays. Specific binding of MDmAb to P.
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Epitopes for MDmAb in P. gingivalis are gingipain
protease domains
Proteins in P. gingivalis containing epitopes for MDmAb were in-
gel trypsin digested and identified by MALDI-TOF mass
spectrometry (MS). Three protein fragments corresponding to
MDmAb immunostaining (45 kDa Band1, 40 kDa Band2 and
32 kDa Band3) were analyzed in repeated MS assays, and
frequently the highest match scores were obtained for gingipains
or hemagglutinin. Arginine-specific gingipain (Rgp) was the most
prevalent result in every MS analysis (see Figures S1, S2, and S3).
Based on this data the recombinant domains of Rgp were
produced in E. coli (Fig. 2A). Catalytic domain (RgpCAT) and two
peptides in adhesin/hemagglutinin domain, Rgp44 and Rgp15–
27, were analyzed for recognition by MDmAb (Fig. 2B). MDmAb
showed strong binding to Rgp44 and Rgp15–27 and only weak
binding to the catalytic domain on Western blot. Anti-PC IgM
control antibody (a-PC-mAb) did not recognize epitopes on
recombinant gingipain domains (Fig. 2B). Competitive immuno-
assay of MDmAb binding to Rgp domains showed specific binding
to Rgp44 but not to Rgp15–27 or RgpCAT (Fig. 2C). MDA-LDL
was an effective competitor for MDmAb binding to Rgp44,
whereas native LDL and PC-BSA did not compete for MDmAb
binding to Rgp44 (Fig. 2D). The molecular weights of the
recombinant Rgps and the gingipain of P. gingivalis cell extract are
very different on SDS-PAGE. Purified gingipain from P. gingivalis
cells has been documented to resolve on SDS-PAGE under
denaturing and reducing conditions to five bands of 45 kDa or less
[46]. Similarly, small protein bands of 30, 27 and 18 kDa of arg-
gingipain have been reported after boiling treatment [47]. In
addition to conditions of SDS-PAGE the other possible explana-
tion for observing gingipain in bands less than 45 kDa in P.
gingivalis lysate is the autoproteolytic activity of the gingipain
protease itself [48].
IgM titers to MDA-LDL are elevated in C57BL/6 and
LDLR2/2 mice after immunization with P. gingivalis
C57BL/6 mice immunized with heat-killed P. gingivalis showed a
significant increase in plasma IgM binding to MDA-LDL
compared to the controls (Fig. 3A). High fat fed LDLR2/2 mice
immunized with killed P. gingivalis had also significantly increased
plasma IgM binding to MDA-LDL compared to controls (Fig. 3C).
Levels of IgM and IgG against MDA-LDL before immunization of
LDLR2/2 mice are shown in the Figure S5. Pg-immunization did
not significantly elevate IgG antibodies to MDA-LDL in C57BL/6
(Fig. 3B) or LDLR2/2 mice (Fig. 3D) compared to the controls.
C57BL/6 and LDLR2/2 mice immunized with P. gingivalis had
elevated titers to Pg-antigens as shown in Table 1. Plasma IgM
binding to CuOx-LDL was also increased in P. gingivalis
immunized C57BL/6 (Fig. 3E) and LDLR2/2 (Fig. 3G) mice,
which was most likely due to the presence of MDA epitopes in
CuOx-LDL as previously shown with other MDA-LDL specific
monoclonal antibodies [11]. Low levels of plasma IgM binding to
PC epitope in BSA carrier (PC-BSA) were observed in the Pg-
immunized C57BL/6 mice (Fig. 3F) whereas the Pg-immunized
LDLR2/2 mice had no increase in plasma IgM binding to PC-
BSA (Fig. 3H). IgM binding to oxidized cardiolipin was not
significantly elevated in C57BL/6 mice immunized with P.
gingivalis compared to control mice (Fig. S4). Plasma lipids were
analyzed in the LDLR2/2 mice at the end of HFD (Table 2). No
significant differences were observed in the plasma total
cholesterol or triglycerides, or LDL and HDL cholesterol levels
between the groups.
Antibody responses to recombinant gingipain in P.
gingivalis immunized mice
Domains of an arginine specific gingipain protease were
produced in E. coli, and mouse plasma IgM and IgG binding to
two recombinant proteins in the hemagglutinin/adhesion domain,
Rgp44 and Rgp15–27, and to recombinant catalytic domain,
RgpCAT, were analyzed with chemiluminescence immunoassay
in P. gingivalis immunized and control groups in both C57BL/6
(Fig. 4A) and LDLR2/2 mice (Fig. 4B). P. gingivalis immunization
increased significantly the IgM binding to Rgp44 and Rgp15–27
compared to controls both in C57BL/6 (Fig. 4A) and in LDLR2/2
mice (Fig. 4B). After P. gingivalis immunization the difference
between IgM binding to RgpCAT was not significant when
comparing immunized C57BL/6 (Fig. 4A) or LDLR2/2 (Fig. 4B)
mice to controls. P. gingivalis immunization increased also IgG
binding to Rgp44 and Rgp15–27 in both mouse strains (Fig. 4A, B),
but IgG responses to RgpCAT seemed to be absent.
Plasma dilution curves of immunized mice
Dilution curves of plasma IgM binding to MDA-LDL, CuOx-
LDL, native LDL and PC-BSA are shown in Figure 5 (A, C)
for C57BL/6 and LDLR2/2 mice. No IgM binding to PC-BSA
was demonstrated on dilution curves of Pg-immunized mouse
plasma of C57BL/6 and LDLR2/2 mice (Fig. 5A, C). Dilution
curves of plasma IgM binding to P. gingivalis and recombinant
gingipain domains Rgp44, Rgp15–27 and RgpCAT are shown
in Figure 5B for C57BL/6 mice and in Figure 5D for LDLR2/2
mice.
Immunization with P. gingivalis increases IgM binding to
apoptotic cells
Plasma samples of the Pg-immunized and control C57BL/6
mice before and after immunization were analyzed for IgM
binding to DAMPs on UV-irradiated apoptotic Jurkat T cells by
flow cytometry (Fig. 6A, B). Pg-immunized mice had significantly
elevated plasma IgM binding to apoptotic cells (Fig. 6C, D)
whereas the controls did not show any increase (Fig. 6D).
Induction of MDA-LDL specific antibodies in response to
bacterial immunization was further verified by competitive
incubation of immune plasma with MDA-modified or native
LDL. MDA-LDL, but not native LDL, competed for IgM binding
to apoptotic cells in Pg-immunized mice resulting in approxi-
mately 20–30% reduction in IgM binding (Fig. 6C, D). Controls
showed no difference in the competitive flow cytometry assay
(Fig. 6D).
P. gingivalis immunization reduces lipid deposition in the
aorta of LDLR2/2 mice
Atheroprotective effect of bacteria bearing MDA-LDL cross-
reactive epitopes was tested by immunizing LDLR2/2 mice with
killed P. gingivalis. Significantly smaller areas of lipid deposition
were measured in Pg-immunized mice compared to controls by en
gingivalis (Pg) and E. coli was tested with competitive chemiluminescence immunoassay (D). Bacterial suspensions were adjusted to an absorbance of
0.15 at 580 nm with PBS and further diluted as indicated. B/B0 indicates the ratio of IgM binding with and without a competitor. RLU, relative light
unit. Binding of MDmAb and isotype control (cntrl_IgM) to P. gingivalis (E) and E. coli (F) in native conditions was tested with flow cytometry.
Fluorescence (FL-1) of the cells with the secondary antibody, +2uAb (red), MDmAb (blue) and isotype control (green).
doi:10.1371/journal.pone.0034910.g001
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face lipid staining analysis (Fig. 7A). Plaque sizes at the aortic origin
of Pg-immunized mice did not differ significantly from the plaques
sizes of the controls (Fig. 7B).
Human serum contains IgM recognizing cross-reactive
epitopes on MDA-LDL and P. gingivalis
The presence of antibodies binding to cross-reactive epitopes on
OxLDL and P. gingivalis was assessed also in humans. Serum
samples (n = 29) were analyzed for IgM binding to MDA-LDL, P.
gingivalis and recombinant gingipain domains with chemilumines-
cence immunoassays. Serum IgM binding to MDA-LDL associ-
ated positively with IgM binding to P. gingivalis (Spearman
r= 0.79, P,0.01) (Fig. 8A) but there was no association between
serum IgG to P. gingivalis and MDA-LDL (Fig. 8B). Recombinant
gingipain domains Rgp44 and RgpCAT competed effectively for
serum IgM binding to MDA-LDL in a dose-dependent manner in
competitive immunoassays (Fig. 8 C, D). Rgp15–27 did not
compete for human serum IgM binding to MDA-LDL (Fig. 8C,
D). Human serum IgM binding to P. gingivalis was effectively
competed with MDA-LDL but not with native LDL or PC-BSA
(Fig. 8E).
Discussion
The present study demonstrated new epitope cross-reactivity
between oxidized LDL and bacterial epitopes. Mouse monoclonal
IgM specific for malondialdehyde modified LDL (MDmAb)
recognized epitopes on the major periodontal pathogen P.
gingivalis. Immunization of mice with killed P. gingivalis increased
plasma IgM binding to MDA-LDL and DAMPs present on
apoptotic cells. Pg-immunization attenuated development of
atherosclerosis in LDLR2/2 mice, and we suggest that one
possible mechanism contributing to the diminished aortic lipid
deposition may have been the induction of IgM antibodies to
MDA-LDL. P. gingivalis proteins recognized by MDmAb were
identified using mass spectrometry, and target epitopes were
located on gingipains, which are special proteases of P. gingivalis
and crucial for its virulence. The positive association between
human serum IgM binding to P. gingivalis and MDA-LDL, and the
Figure 2. Identification of P. gingivalis epitopes for anti-MDA-LDL-IgM. A) Schematic presentation of arg-gingipain (RgpA) functional
domains cloned and produced in a recombinant system [41]. B) Proteins of P. gingivalis were separated on SDS-PAGE (Pg, gel). Fragments recognized
by MDmAb (45, 40 and 32 kDa, black arrows) were identified by mass spectrometry as arginine-specific gingipain or hemagglutinin A of P. gingivalis.
Figures S1, S2, S3 contain the Mascot results of the database searches and the MSMS spectrum showing the matching amino acids in the peptide
sequence. Three domains of the recombinant arg-specific gingipain, RgpCAT, Rgp44 and Rgp15–27 were produced in E. coli and analyzed for
recognition by MDmAb and anti-PC-IgM control antibody (a-PC-mAb). C) Specific binding of MDmAb to recombinant gingipain domains Rgp15–27,
Rgp44 and RgpCAT was tested with a competitive immunoassay. D) Reciprocally, soluble MDA-LDL, nLDL and PC-BSA were used as competitors for
MDmAb binding to Rgp44. B/B0 indicates the ratio of IgM binding with and without a competitor. MW, molecular weight. PC-BSA, phosphocholine-
conjugated bovine serum albumin.
doi:10.1371/journal.pone.0034910.g002
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recognition of recombinant gingipain domains by serum IgM
suggested relevance of these findings also in humans.
Natural IgM antibodies bind to oxidized lipid and protein
epitopes generated on various molecules including LDL particle
undergoing oxidation and ageing cells exposed to burst of
oxidative stress [10]. At least two types of epitopes on oxidized
phospholipids are previously reported to display molecular
mimicry with epitopes on microbes. Many bacteria express
epitopes containing PC, including approximately 30% of the
strains colonizing the oral cavity such as Aggregatibacter actinomyce-
temcomitans, Fusobacterium nucleatum and Streptococcus sanguis [49,50].
Bacterial strains can be classified as PC-bearing or devoid of PC
according to their ability to incorporate choline from the culture
medium [30]. A significant human pathogenic bacterium
Figure 3. Mouse plasma IgM and IgG binding to MDA-LDL after immunization with P. gingivalis. C57BL/6 mice were immunized with
heat-killed P. gingivalis ATCC33277 (Pg; n = 8) and controls received saline (Co; n = 8). Plasma IgM (A) and IgG (B) to MDA-LDL before (pre) and after
immunization (post) were determined with chemiluminescence immunoassay. Each C57BL/6 plasma sample (1:500) was measured in duplicate and
an average for each individual was calculated. LDLR2/2 mice were immunized with killed P. gingivalis (3 strains mixed) (Pg; n = 7) and controls
received PBS (Co; n = 8). Plasma IgM (C) and IgG (D) to MDA-LDL after the second booster immunization (imm) and after the HFD (end) were
determined. Each LDLR2/2 plasma sample (1:1000) was measured in duplicate and an average for each individual in two repeated assays was
calculated. Additionally, mouse plasma IgM binding to CuOx-LDL (E, G) and PC-BSA (F, H) was determined. For C57BL/6 mice (E, F) this was done
similarly as described for panel A. Plasma samples of LDLR2/2 mice (G, H) were pooled between three or four mice (1:1000) for a single assay, in
which the mean 6 SD within a group is shown.
doi:10.1371/journal.pone.0034910.g003
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Streptococcus pneumoniae bears PC epitopes on its cell wall, and there
is evidence that PC induces protective immune response in animal
models of pneumococcal infection [51]. Natural IgMs in mice are
reported to recognize the PC moiety on S. pneumoniae cell wall
polysaccharide and on the oxidized phospholipids on LDL [7].
Association studies show an inverse relationship between anti-PC
IgM and risk for CVD, however, human IgM antibodies
recognizing bacterial PC epitopes have not been shown to play
a definite role in atherogenesis [20]. Elevated anti-PC antibodies
have been demonstrated in periodontitis patients compared to
those with no attachment loss [30] and to those with less
suppuration [52]. Studies also demonstrate recognition of PC
moieties on oxidized LDL by serum and gingival crevicular fluid
anti-PC antibodies [50,53]. The other oxidized epitope displaying
molecular mimicry with bacterial epitopes is cardiolipin, a
phospholipid located in the inner leaflet of mitochondria and
present also in OxLDL and bacteria. Cardiolipin is oxidized
during apoptosis, and natural antibodies to oxidized cardiolipin
bind to apoptotic cells and OxLDL [45]. IgG-antibodies to both
PC [30] and cardiolipin [54] have been shown to associate with
both atherosclerosis and periodontitis.
Bacterial strains devoid of PC are able to absorb anti-OxLDL
antibodies from human sera [53] suggesting presence of additional
cross-reactive epitopes in oral bacteria. Based on that, we
determined to screen few bacterial species for recognition by
anti-MDA-LDL IgM antibodies. Since some P. gingivalis strains
have previously been determined as devoid of PC [30], we wanted
to analyze the cross-reactivity of anti-OxLDL antibodies with
bacterial epitopes other than PC. Natural IgMs binding to MDA
epitopes were chosen for the study since MDA is the most
abundant reactive aldehyde generated by lipid peroxidation in
biological systems, and IgM antibodies binding to MDA-modified
proteins have been described in humans [12,17].
Apoptosis is known to generate DAMPs on cell membrane
phospholipids and proteins due to disturbed integrity of the bilayer
membrane and oxidative attack [55,56]. Recognition of apoptotic
cells containing oxidized lipids and proteins is a well-characterized
feature of natural IgM antibodies [10,18,45,55]. Monoclonal IgM
selected for binding to either the PC moiety or the MDA epitopes
on LDL bind to apoptotic, but not to viable cells, and in addition,
these IgMs inhibit phagocytosis of apoptotic cells by macrophages
[55]. To our knowledge no previous reports describe the increased
IgM binding to apoptotic cells in mice following immunization
with killed bacteria, such as the periodontal pathogen P. gingivalis
in the present study. MDA-LDL competed effectively with the
post-immunization plasma for the IgM binding to apoptotic cells
yielding 20–30% reduction in IgM binding. This finding suggests
that bacterial antigenic stimuli induced production of IgM that
recognizes MDA-LDL through molecular mimicry. However, the
rest of the induced IgM was presumably directed towards epitopes
other than MDA, since whole cell bacterial antigen was used for
immunizations, and therefore, it is likely that additional immune
responses were generated against various other bacterial epitopes.
Presumably many different bacteria contain epitopes that are
recognized by natural IgMs binding to MDA epitopes, and thus, it
can be hypothesized that IgM binding to apoptotic cells could also
increase upon immunization with other bacteria, not only P.
gingivalis.
The present study showed reduced lipid deposition in the aorta
suggesting attenuation of atherogenesis after immunizing LDLR2/2
mice with killed P. gingivalis. This is in accordance with the previous
studies [25,26,28] all performed with apoE -deficient mice that
spontaneously develop lesions even on regular chow diet [57]. In this
study we used LDLR2/2 mice which have no considerable lesion
progression before starting the HFD [58]. We also immunized
C57BL/6 mice with P. gingivalis and demonstrated the increased IgM
binding to MDA-LDL even without atherogenic diet. The result
suggests that epitopes on bacteria, for example gingipain of P.
gingivalis, induce production of natural IgM capable of binding to
OxLDL independently of excess cholesterol. C57BL/6 and
LDLR2/2 mice immunized with killed P. gingivalis had a similar
pattern of anti-MDA-LDL antibody production; IgM binding to
MDA-LDL was increased but IgG antibodies with this specificity
were not produced. We suggest that bacterial immunization
induces anti-MDA-LDL IgM production, which could prevent
the progression of atherosclerosis by diminishing uptake of
Table 1. Plasma antibody levels to P. gingivalis in immunized mice.
Antibodies to Pg (RLU/100 ms) C57BL/6* LDLR2/2{
Group pre post pre immunized after HFD
Pg IgM 3396182 15296750 202622 198861293 1091762642
Pg IgG 274662 2128467410 175676 580564130 676166558
controls IgM 291677 3726107 2316132 219643 4236121
controls IgG 317677 331692 191642 267695 235653
*C57BL/6 female mice (n = 8 per group) were immunized with heat-killed P. gingivalis (Pg) (ATCC33277) and controls received saline. Plasma IgM and IgG to Pg before
(pre) and after immunization (post) were determined with chemiluminescence immunoassay. Values are mean 6 SD. RLU, relative light units.
{LDLR2/2 mice were immunized with killed P. gingivalis (n = 7 in Pg-immunized and n= 8 in PBS-controls) and plasma IgM and IgG to Pg before (pre), after the second
booster immunization (immunized) and after the high fat diet (HFD) were determined. Values are mean 6 SD. RLU, relative light units.
doi:10.1371/journal.pone.0034910.t001
Table 2. Weight gain and plasma lipids of LDLR2/2 mice.
Pg-immunized* controls*
weight at start point of HFD (g) 28.462.5 30.564.2
Increase in weight during HFD (%) 6.364.7 7.465.0
HDL cholesterol (mmol/l){ 12.463.7 13.264.3
LDL cholesterol (mmol/l){ 25.569.2 30.369.1
total plasma cholesterol (mmol/l){ 40613 47615
total plasma triglycerides (mmol/l){ 6.462.6 7.663.6
*Female LDLR2/2 mice were immunized with killed P. gingivalis (n = 7) and
controls (n = 8) received PBS. Mean 6 SD is shown.
{Plasma lipids were measured from EDTA-plasma samples collected
immediately after sacrifice at the end of HFD. Concentration of LDL cholesterol
was estimated using the formula of Friedewald.
doi:10.1371/journal.pone.0034910.t002
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Figure 4. Antibodies to recombinant gingipain in P. gingivalis immunized mice. Recombinant proteins of the arginine specific gingipain
protease of P. gingivalis were produced in E.coli: two proteins in the hemagglutinin/adhesion domain, Rgp44 and Rgp15–27, and the catalytic
domain, RgpCAT, which were used in chemiluminescence immunoassay to determine mouse plasma (1:500) IgM and IgG binding in P. gingivalis
immunized (Pg) and control (Co) groups in both A) C57BL/6 and B) LDLR2/2 mice. A) For C57BL/6 immunized and control mice the samples (n = 8
each) were determined as duplicate before (pre) and after (post) immunization. Box-plots represent the distribution of the means of the sample
duplicates. B) Two plasma samples within the group were pooled for immunized (black bars) and control (hatched bars) LDLR2/2mice and measured
in duplicate. Samples were collected before (pre), after the second booster immunization (imm) and at the end of HFD (end). Columns represent the
mean 6 SD of pooled samples in each group. **P,0.01 and *P,0.05.
doi:10.1371/journal.pone.0034910.g004
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Figure 5. Dilution curves of mouse plasma IgM binding to antigens. A, B) C57BL/6 mice were immunized with heat-killed P. gingivalis
ATCC33277 (Pg) and controls (Co) received saline. The plasma was diluted 1:100–1:6400 and IgM binding to MDA-LDL, CuOx-LDL, native LDL, PC-BSA
(A), P. gingivalis and recombinant gingipain domains Rgp44, Rgp15–27 and RgpCAT (B) were determined before (pre) and after (post) immunization
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OxLDL by macrophages and thereby reduce the formation of foam
cells at sites of developing atherosclerotic lesions. Our data on Pg-
immunizations also suggests that only innate IgM antibodies
recognizing OxLDL were produced whereas IgG to OxLDL was
absent.
The specificity of natural IgM to MDA epitopes induced after
immunization with P. gingivalis was evaluated by additional
measurements of IgM binding to PC-BSA and CuOx-LDL,
which contains PC epitopes. Both C57BL/6 and LDLR2/2 mice
immunized with P. gingivalis showed elevated IgM binding to
CuOx-LDL but there was no substantial increase in IgM binding
to PC when conjugated with a simple BSA carrier molecule.
CuOx-LDL contains several types of oxidization-derived epitopes
and MDA-epitopes have been reported [11] to be among them
besides the major epitope type of phosphocholine.
The present study showed that epitopes for MDmAb binding on
P. gingivalis are sequences in gingipain proteases. Gingipain amino
acid sequence contains numerous repeated sequences [59] which
are possibly explaining the observed differences in the recognition
of the three recombinant Rgp domains by mouse and human IgM.
Different exposure to antigens between humans and mice and
polyclonal nature of serum IgM might additionally explain the
different binding patterns of gingipain recognition. The different
binding pattern of MDmAb to Rgp15–27 in Western blot and
competitive liquid-phase immunoassays can be due to differences
in the experimental conditions i.e. reducing and denaturing versus
the native liquid-phase. Additionally, the different binding pattern
can be due to conformational changes revealing cryptic epitope
presentation similar to that described e.g. for autoantibodies
binding to b2-glycoprotein 1 [60,61].
The identified targets for MDmAb, the gingipain proteases,
have been characterized in-depth [62], and interestingly, proposed
as potential targets for protective vaccination against periodontitis
[46,63]. However, none of the previous work describes the binding
of natural IgM to gingipain of P. gingivalis. Human and mouse
monoclonal IgG antibodies binding to hemagglutinin domain of
with chemiluminescence immunoassay. Mean 6 SD for two samples is shown. C, D) LDLR2/2 mice were immunized with killed P. gingivalis (3 strains
mixed) (Pg) and controls (Co) received PBS. Pooled plasma from two mice was used for each dilution curve, and mean6 SD for two dilution curves is
shown. IgM binding to MDA-LDL, CuOx-LDL, native LDL, PC-BSA (C), P. gingivalis and recombinant gingipain domain Rgp44, Rgp15–27 and RgpCAT
(D) were determined before (pre) and after the second booster immunization (imm) as described.
doi:10.1371/journal.pone.0034910.g005
Figure 6. Mouse plasma IgM binding to apoptotic T lymphocytes after P. gingivalis immunization. C57BL/6 mice were immunized with
heat-killed Pg and controls received sterile saline (n = 8 per group). Mouse plasma (1:70) IgM binding to UV-irradiated Jurkat T cells was measured
with flow cytometry. A, B) Apoptotic T cell population (R1) was verified with propidium iodide (PI) staining. C) Plasma IgM binding in gate R2 of
preimmune (black) and postimmune (blue) plasma samples, and competition of IgM binding with 250 mg/ml MDA-LDL (green) or native LDL (red).
Inset plots (in Fig. 6C) represent the secondary antibody control (2uAb control) and plasma IgM binding to apoptotic cells in a Pg-immunized mouse
(post). D) IgM binding to Jurkat cells was determined for each mouse in Pg-immunized and control group as geometric mean value in R2 subtracted
by the 2uAb control. Box-plot graphs represent the distribution of sample means calculated for two repeated assays. **P,0.01 and *P,0.05.
doi:10.1371/journal.pone.0034910.g006
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gingipain have been described and shown to inhibit hemaggluti-
nating activity of P. gingivalis [64]. These studies [63,64]
demonstrate recognition of similar sized protein fragments as
those identified by MDmAb of the present study. Epitope mapping
of these IgGs has revealed peptide sequences (e.g. PVQNLT) that
are present on gingipain hemagglutinin domain [64]. The true
identity of the epitope on gingipain that is recognized by the
MDA-specific IgM remains yet to be solved, and the question
remains open whether the molecular mimicry between MDA-
LDL and gingipain is only recognized by natural IgM or could
anti-gingipain-IgG antibodies also play a role.
Intriguingly, the present data can be linked to numerous
association studies establishing that periodontal infections increase
risk for developing atherosclerosis [21,65]. In more detail, high
serum IgG titers to P. gingivalis have been shown to predict
myocardial infarction [66], and additionally, antibody responses to
other periodontal pathogens are associated with CVD [22]. The
epitope cross-reactivity of MDA-LDL and P. gingivalis gingipain
suggests recognition by similar types of natural IgM clones in
humans and mice. Further, our hypothesis is that these types of
natural IgM could confer protection against harmful agents
associated with the development of periodontitis-induced athero-
sclerosis. To obtain further confirmation for the hypothesis, a
highly relevant experiment would be an immunization of mice
with recombinant Rgp44 cloned from the adhesion/hemaggluti-
nin domain of P. gingivalis gingipain followed by the introduction of
atherogenic diet. If the peptide sequence of Rgp44 could elicit
elevated levels of IgM binding to MDA-LDL, the Rgp44-
immunization could result in amelioration of atherosclerosis.
Plasma IgM binding to MDA-LDL has been described in cohort
studies on a population level and it has been associated with the
risk for atherosclerosis [12,67]. Thus, we conclusively suggest that
alteration in each individual’s natural antibody repertoire against
MDA-modified oxidized epitopes could also affect recognition and
elimination of periodontitis pathogens.
Molecular mimicry between epitopes on MDA-LDL and P.
gingivalis gingipain protease was shown to be recognized by natural
IgM of the innate immune system. Nevertheless, the role of the
previously characterized cross-reactivity of the PC epitope
between OxLDL and bacteria recognized by natural monoclonal
antibodies [7,31] other than the MDmAb of the present study
should not be omitted. The present study broadens furthermore
the notion of various PAMPs present on OxLDL and bacteria, and
possibly offers new insights into resolving the relationship between
periodontal infections and atherosclerosis.
Supporting Information
Figure S1 Protein identification for 45 kDa band 1. A)
Mascot score histogram. Individual ions scores .26 indicate
identity or extensive homology (P,0.05), protein scores are derived
from ions scores as a non-probabilistic basis for ranking protein
hits. B) Gingipain amino acid sequence with the matching tryptic
cleavage peptide sequence highlighted in red. C) MSMS spectrum
showing the matching amino acids in the peptide sequence.
(PPT)
Figure S2 Protein identification for 40 kDa band 2. A)
Mascot score histogram. Individual ions scores .26 indicate
identity or extensive homology (P,0.05), protein scores are
derived from ions scores as a non-probabilistic basis for ranking
protein hits. Gingipain R2 (RgpB) was also identified as a protein
matching the same set of peptides. (score 89, not shown). B)
Gingipain amino acid sequence with the matching tryptic cleavage
peptide sequence highlighted in red. C) MSMS spectrum showing
the matching amino acids in the peptide sequence.
(PPT)
Figure S3 Protein identification for 32 kDa band 3. A)
Mascot score histogram. Individual ions scores .26 indicate
identity or extensive homology (P,0.05), protein scores are derived
from ions scores as a non-probabilistic basis for ranking protein hits.
B) Hemagglutinin A amino acid sequence with the matching tryptic
cleavage peptide sequences highlighted in red. C) MSMS spectrum
showing the matching amino acids in the peptide sequence.
(PPT)
Figure S4 IgM binding to oxidized cardiolipin. Cardio-
lipin (CL) in ethanol was purchased from Sigma Aldrich (St. Louis,
MO, USA) and used 30 mg/ml in absolute ethanol for coating
microtiter plates 25 ml/well during 20 min evaporation in a hood.
Then CL was allowed to oxidize at room temperature for
3.5 hours before mouse plasma (1:500) or monoclonal IgM
(MDmAb or LRO1, 2.5 mg/ml) samples diluted in 0.5% fish
gelatin were added [45]. Chemiluminescence immunoassay was
continued as described in the article text. A) Mouse monoclonal
IgM specific for MDA-LDL (MDmAb) or oxidized CL (LRO1)
was tested for binding to P. gingivalis antigen representing either the
strain ATCC33277 only or three strains (ATCC 33277, W50 and
OMGS 434) mixed and absorbance of the solution was adjusted to
0.15 at 580 nm. B) IgM binding to CL in C57BL/6 mice
immunized with P. gingivalis (Pg) and in saline immunized controls
(Co) before (pre) and after immunization (post). For each mouse
Figure 7. Quantification of atherosclerosis in LDLR2/2 mice
immunized with P. gingivalis. LDLR2/2 mice (n = 7) were immunized
without adjuvant with killed P. gingivalis (3 strains mixed) (Pg) followed
by high fat diet (HFD). Controls (PBS, n = 8) received PBS. A) The extent
of atherosclerotic plaque development was determined after HFD by en
face analysis of the Sudan IV -stained aortas. B) Lesions at the aortic
origin were measured on histological sections as percentage of plaque
area in the aorta cross-sectional area. Representative pictures of aortas
and cross-sections are shown for each group. * P,0.05.
doi:10.1371/journal.pone.0034910.g007
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the background of IgM binding to ethanol coated plate was
subtracted. RLU, relative light units.
(PDF)
Figure S5 Antibodies to MDA-LDL before immunization
of LDLR2/2mice. Plasma IgM and IgG binding to MDA-LDL
was determined with chemiluminescence immunoassay in P.
gingivalis (Pg, n = 7) or control immunized (Co, n = 8) LDLR2/2
mice. All plasma samples were diluted 1:1000, and samples before
immunization (pre) were analyzed for each mouse separately in
duplicate. As an assay control demonstrating the relative
differences in antibody binding the samples after second booster
immunization (imm) and at the end of hig fat diet (end) were
prepared for both groups (Pg and Co) by pooling leftover plasma
samples between 2, 3 or 4 mice.
(PDF)
Methods S1
(DOC)
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